Equities

Achieve Life Sciences Inc

Achieve Life Sciences Inc

Actions
  • Price (EUR)4.37
  • Today's Change0.175 / 4.18%
  • Shares traded--
  • 1 Year change+11.92%
  • Beta--
Data delayed at least 15 minutes, as of Nov 12 2024 20:52 GMT.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Cash flow in USDView more

In 2023, cash reserves at Achieve Life Sciences Inc fell by 9.23m. Cash Flow from Financing totalled 15.28m or -- of revenues. In addition the company used 24.48m for operations while cash used for investing totalled 21.00k.
Cash flow per share--
Price/Cash flow per share--
Book value per share0.9124
Tangible book value per share0.8524
More ▼

Balance sheet in USDView more

Achieve Life Sciences Inc has a Debt to Total Capital ratio of 23.84%, a lower figure than the previous year's 401.07%.
Current ratio6.78
Quick ratio--
Total debt/total equity0.313
Total debt/total capital0.2384
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.